ArticleFrontiers in surgery2026
Indocyanine green fluorescence angiography in laparoscopic sigmoid and rectal cancer surgery: no reduction in anastomotic leakage but a lower incidence of anastomotic strictures. A prospective single-center study.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07423130 (Indocyanine Green Fluorescence Angiography in Laparoscopic Sigmoid and Rectal Cancer Surgery), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Indocyanine Green Fluorescence Angiography in Laparoscopic Sigmoid and Rectal Cancer Surgery: A Prospective Single-Center Observational Study With a Historical Control Group
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Anastomotic leakage (AL) remains one of the most serious complications after colorectal cancer surgery and is closely linked to postoperative morbidity and poorer oncologic outcomes. Intraoperative indocyanine green fluorescence angiography (ICG-FA) has been introduced to allow real-time assessment of bowel perfusion; however, its role in reducing AL is still debated. Therefore, the primary aim of this study was to evaluate whether intraoperative ICG-FA, compared with standard visual assessment, reduces the rate of anastomotic leakage in patients undergoing laparoscopic sigmoid or rectal cancer resection. The secondary aims were to assess its impact on the incidence of anastomotic strictures, overall postoperative complications, reoperation rates, length of hospital stay, readmission, and 30-day mortality. Methods: We conducted a prospective single-center study with a retrospective historical control group, including consecutive patients undergoing laparoscopic sigmoid or rectal cancer resection. Patients who underwent intraoperative ICG-FA between October 2023 and January 2025 were compared with those undergoing similar procedures without fluorescence assessment. The primary endpoint was AL within 30 days. Secondary outcomes included anastomotic stricture within six months, postoperative complications, reoperation, length of hospital stay, readmission, and mortality. Results: A total of 113 patients were analyzed, including 34 in the ICG-FA group and 79 in the control group. The AL rate did not differ significantly between groups (14.7% vs. 12.7%, Conclusion: Intraoperative ICG-FA did not significantly reduce the rate of AL but was associated with a lower incidence of anastomotic strictures. These results imply that fluorescence-guided perfusion assessment may help improve anastomotic healing beyond just preventing clinically evident leakage. Larger prospective multicenter studies are needed to verify these findings. Clinical trial registration: https://clinicaltrials.gov/study/NCT07423130, ClinicalTrials.gov NCT07423130.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.